Uday Kompella
Founder presso OCUGEN, INC.
Patrimonio netto: 1 M $ in data 31/03/2024
Posizioni attive di Uday Kompella
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| OCUGEN, INC. | Director/Board Member | 27/09/2019 | - |
| Founder | 01/01/2013 | - | |
| Independent Dir/Board Member | 27/09/2019 | - | |
| Ocugen OpCo, Inc. | Director/Board Member | 01/09/2013 | - |
| Founder | 01/09/2013 | - | |
| CU Anschutz Medical Campus | Corporate Officer/Principal | - | - |
Storia della carriera di Uday Kompella
Precedenti posizioni note di Uday Kompella
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Ocugen, Inc. /Old/
 Ocugen, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ocugen, Inc. operates as a clinical stage biopharmaceutical firm. It discovers, develops, and commercializes therapies for rare and underserved eye diseases. The firm offers a robust and diversified ophthalmology portfolio that includes novel gene therapies, biologics, and small molecules. The company was founded by Shankar Musunuri and Uday Kompella in 2013 and is headquartered in Malvern, PA. | Director/Board Member | 01/01/2013 | - |
| Chief Tech/Sci/R&D Officer | 01/01/2013 | - | |
| Founder | 01/01/2013 | - |
Formazione di Uday Kompella
| University of Southern California | Doctorate Degree |
| Birla Institute of Technology & Science | Undergraduate Degree |
| Jadavpur University | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
| India | 3 |
| 2 |
Posizioni
| Director/Board Member | 3 |
| Founder | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
Settori
| Consumer Services | 5 |
| Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| OCUGEN, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Ocugen, Inc. /Old/
Ocugen, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ocugen, Inc. operates as a clinical stage biopharmaceutical firm. It discovers, develops, and commercializes therapies for rare and underserved eye diseases. The firm offers a robust and diversified ophthalmology portfolio that includes novel gene therapies, biologics, and small molecules. The company was founded by Shankar Musunuri and Uday Kompella in 2013 and is headquartered in Malvern, PA. | Health Technology |
| Ocugen OpCo, Inc. |
- Borsa valori
- Insiders
- Uday Kompella
- Esperienza
